Phase 2 Lung Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged between 18 and 70 years old
- People with a performance status score of 0 or 1 on the ECOG scale, meaning they are fully active or have only minor limitations in physical activity (confirm with trial site)
- People whose heart, liver, kidneys, and other organs are working well enough to handle chemotherapy, immunotherapy, and radiation treatment
- People who have been diagnosed with small-cell lung cancer
- People whose cancer has been confirmed as "extensive stage" (meaning it has spread more widely) based on scans such as MRI of the brain, CT of the chest, ultrasound of the abdomen, bone scan, or PET-CT
- People who are willing to sign the trial's informed consent form
Who may not be able to join:
- People younger than 18 or older than 70 years old
- People with an ECOG performance status score higher than 1, meaning significant limitations in daily physical activity (confirm with trial site)
- People whose organ function is not strong enough to safely receive chemotherapy, immunotherapy, or radiation treatment
- People diagnosed with non-small-cell lung cancer or other related tumour types, including typical or atypical carcinoid tumours or large-cell neuroendocrine carcinoma
- People whose cancer has been confirmed as "limited stage" (meaning it is more contained) based on the scans listed above
- People who are not willing or able to sign the informed consent form
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Dong Qian, M.D, Anhui Provincial Hospital
Phone: +8619156007756
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Progression-free Survival
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.